Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...

Compared with a placebo injection, platelet-rich plasma injections yielded similar outcomes at 1 year for patients with ...

Darolutamide may offer greater benefits than enzalutamide or apalutamide for Black and White patients with non-metastatic ...

Discover how Ultragenyx achieved 29% revenue growth in 2024, set 2025 guidance at $640M-$670M, and advanced clinical progress toward profitability by 2027.

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...

Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic ...

AI, when properly implemented, has the power to transform emergency medicine by enhancing patient outcomes, reducing ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of additional years of healthy life globally. Some examples of disease areas in which ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and patient-important outcomes.

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...

Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.

The conundrum of missing data vs. inter-rater variability.